Real or Perceived: Hyperkalemia Is a Major Deterrent for Renin-Angiotensin Aldosterone System Inhibition in Heart Failure

Nephron. 2018;138(3):173-175. doi: 10.1159/000485645. Epub 2017 Dec 5.

Authors

Peter A McCullough^{1

2

3}, Janani Rangaswami^{4

5}

Affiliations

¹ Baylor University Medical Center, Dallas, Texas, USA.
² Baylor Heart and Vascular Institute, Dallas, Texas, USA.
³ Baylor Jack and Jane Hamilton Heart and Vascular Hospital, Dallas, Texas, USA.
⁴ Department of Medicine, Division of Nephrology, Einstein Medical Center, Philadelphia, Pennsylvania, USA.
⁵ Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

PMID: 29207385
DOI: 10.1159/000485645

No abstract available

Publication types

Review

MeSH terms

Angiotensin-Converting Enzyme Inhibitors / adverse effects
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Heart Failure / complications*
Heart Failure / drug therapy*
Humans
Hyperkalemia / complications*
Hyperkalemia / epidemiology
Mineralocorticoid Receptor Antagonists / adverse effects
Mineralocorticoid Receptor Antagonists / therapeutic use
Renal Insufficiency, Chronic / complications
Renin-Angiotensin System / drug effects*

Substances

Angiotensin-Converting Enzyme Inhibitors
Mineralocorticoid Receptor Antagonists